NI-1201
NI-1201 is a monoclonal antibody that targets, in the human IL-6R sequence, the epitope recognized by 25F10 for mice. NI-1201 inhibits both IL-6 cis- and trans-signaling. NI-1201 targets site IIb of hIL-6R. NI-1201 inhibits gp130 binding to IL-6R[1].
Product Specifications
Product Name Alternative
TZLS-501
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Lacroix, M., et al., (2015) . Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex. The Journal of biological chemistry, 290 (45), 26943–26953.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
036451-ML490 100 µL
HBS1L, ID (HBS1L, HBS1, KIAA1038, HBS1-like protein, ERFS) (MaxLight 490) discontinued
Ask
View Details ![1-Benzyl-4-[ (5-benzyloxy-6-methoxy-1-indanone) -2-ylidenyl]methylpiperidine](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
262368-01 5 mg
1-Benzyl-4-[ (5-benzyloxy-6-methoxy-1-indanone) -2-ylidenyl]methylpiperidine
Ask
View Details 262368-02 10 mg
1-Benzyl-4-[ (5-benzyloxy-6-methoxy-1-indanone) -2-ylidenyl]methylpiperidine
Ask
View Details 262368-03 25 mg
1-Benzyl-4-[ (5-benzyloxy-6-methoxy-1-indanone) -2-ylidenyl]methylpiperidine
Ask
View Details 262368-04 50 mg
1-Benzyl-4-[ (5-benzyloxy-6-methoxy-1-indanone) -2-ylidenyl]methylpiperidine
Ask
View Details